Retinoic acid-loading of the major birch pollen allergen Bet v 1 may improve specific allergen immunotherapy: In silico, in vitro and in vivo data in BALB/c mice

Karin Hufnagl, Sheriene Moussa Afify, Nina Braun, Stefanie Wagner, Michael Wallner, Michael Hauser, Markus Wiederstein, Gabriele Gadermaier, Sabrina Wildner, Frank A. Redegeld, Bart R. Blokhuis, Gerlinde Hofstetter, Isabella Pali-Schoell, Franziska Roth-Walter, Luis F. Pacios, Erika Jensen-Jarolim

Research output: Contribution to journalLetter

Original languageEnglish
JournalAllergy: European Journal of Allergy and Clinical Immunology
DOIs
Publication statusPublished - 16 Apr 2020

Fields of Science and Technology Classification 2012

  • 301 Medical-Theoretical Sciences, Pharmacy

Keywords

  • Bet v 1
  • birch pollen allergy
  • immunotherapy
  • mouse model
  • retinoic acid

Cite this

Hufnagl, K., Afify, S. M., Braun, N., Wagner, S., Wallner, M., Hauser, M., Wiederstein, M., Gadermaier, G., Wildner, S., Redegeld, F. A., Blokhuis, B. R., Hofstetter, G., Pali-Schoell, I., Roth-Walter, F., Pacios, L. F., & Jensen-Jarolim, E. (2020). Retinoic acid-loading of the major birch pollen allergen Bet v 1 may improve specific allergen immunotherapy: In silico, in vitro and in vivo data in BALB/c mice. Allergy: European Journal of Allergy and Clinical Immunology. https://doi.org/10.1111/all.14259